Company Filing History:
Years Active: 2018-2022
Title: The Innovative Contributions of Jonathan Rios-Doria
Introduction
Jonathan Rios-Doria is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents targeting CD73. With a total of 4 patents to his name, Rios-Doria's work is paving the way for advancements in cancer treatment.
Latest Patents
One of Rios-Doria's latest patents focuses on binding molecules specific for CD73 and their uses. This patent provides anti-CD73 binding molecules, including antibodies and antigen-binding fragments. The disclosed compositions are designed for pharmaceutical formulations aimed at diagnosing and treating diseases associated with CD73 expression, such as cancer. The treatment methods include direct therapy with the anti-CD73 binding molecules, adjuvant therapy with other anticancer agents, and combination therapies that may involve chemotherapy.
Career Highlights
Rios-Doria is currently employed at MedImmune Limited, where he continues to innovate in the field of biopharmaceuticals. His work is instrumental in developing new therapeutic strategies that can significantly impact patient outcomes in oncology.
Collaborations
Throughout his career, Rios-Doria has collaborated with esteemed colleagues, including Carl Hay and Kris Sachsenmeier. These partnerships have fostered a collaborative environment that enhances the research and development of novel therapeutic agents.
Conclusion
Jonathan Rios-Doria's contributions to the field of biotechnology and his innovative patents are making a significant impact on cancer treatment. His work exemplifies the importance of research and collaboration in advancing medical science.